Skip to Content

The Best Datreal Yet: Real Estate Maps, a New Design, Dark Mode. Read the Changelog

Datreal

EstPharma OÜ - Company Valuation

Reference Value. Equity as reported in the selected filing.

Reported Book Equity

0 €
Reference Value
Based on FY
2025
Valuation Date
Business Strength
F
Risks
Negative EquityDistressedLoss-Making

Scope & Evidence

Company
EstPharma OÜ
Registration
EE · 14915921
Covers
Single Company
Filings Used
6 · FY 2025, 2024, 2023, 2022, 2021, 2020

Key Ratios

Current Ratio
0.61×
Quick Ratio
-
Debt / Equity
-
Equity Ratio
-63.6%
Interest Coverage
-
Gross Margin
-
Net Profit Margin
-5.0%
Return on Equity
-
Return on Assets
-35.6%
Revenue CAGR
14.6%

Liability Maturity

Short-Term

3-Year Revenue Scenarios

12m €
9m €
6m €
3m €
0 €
202620272028
OptimisticBaseConservative

Revenue vs Industry Peers

Aaloe Apteegid OÜ
25,205,241 €
osaühing TARTU UUSAPTEEK
21,012,136 €
Eyrekodu OÜ
6,819,467 €
Farmalpluss OÜ
6,713,301 €
EstPharma OÜ ★
5,282,539 €
Farmaking OÜ
2,814,570 €

Revenue, Profit & EBITDA

6m €
4m €
2m €
0 €
-2m €
20212022202320242025
RevenueNet Profit

Versus Industry Median

6m €
4m €
2m €
0 €
-2m €
RevenueNet Profit
This CompanyIndustry Median